Z-1492-2023 Class I Ongoing
FDA device recall Z-1492-2023 was initiated by Cordis US Corp on Mar 24, 2023 and is designated Class I. Reason for recall: There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous… The recall status is ongoing. Affected quantity: 1058 units.
Recall details
- Product Type
- Devices
- Report Date
- May 17, 2023
- Initiation Date
- Mar 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1058 units
Product description
ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 601814RE
Reason for recall
There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.
Distribution pattern
Worldwide distribution.
Code information
UDI/DI 20705032056714; Lot Numbers: 35264218, 35264224, 35264806, 35265342, 35265343, 35265382, 35265383, 35265646, 35265656, 35265658, 35264206, 35265645, 35265653
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1492-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026